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Abstract
Purpose In the study of microbial keratitis, in vivo animal
models often require a large number of animals, and in vitro
monolayer cell culture does not maintain the three-
dimensional structure of the tissues or cell-to-cell communi-
cation of in vivo models. Here, we propose reproducible
ex vivo models of single- and dual-infection keratitis as an
alternative to in vivo and in vitro models.
Methods Excised rabbit and human corneoscleral rims main-
tained in organ culture were infected using 108 cells of
Staphylococcus aureus, Pseudomonas aeruginosa, Candida
albicans or Fusarium solani. The infection was introduced
by wounding with a scalpel and exposing corneas to the mi-
crobial suspension or by intrastromal injection. Post-inocula-
tion, corneas were maintained for 24 and 48 h at 37 °C. After
incubation, corneas were either homogenised to determine
colony-forming units (CFU)/cornea or processed for histolog-
ical examination using routine staining methods. Single- and
mixed-species infections were compared.
Results We observed a significant increase in CFU after 48 h
compared to 24 h with S. aureus and P. aeruginosa. However,
no such increase was observed in corneas infected with
C. albicans or F. solani. The injection method yielded an
approximately two- to 100-fold increase (p < 0.05) in the
majority of organisms from infected corneas. Histology of
the scalpel-wounded and injection models indicated extensive
infiltration of P. aeruginosa throughout the entire cornea, with
less infiltration observed for S. aureus, C. albicans and
F. solani. The models also supported dual infections.
Conclusions Both scalpel wounding and injection methods
are suitable for inducing infection of ex vivo rabbit and human
cornea models. These simple and reproducible models will be
useful as an alternative to in vitro and in vivo models for
investigating the detection and treatment of microbial kerati-
tis, particularly when this might be due to two infective
organisms.
Keywords Ex vivo cornea .Microbial keratitis .
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Introduction
Microbial keratitis is a major problem worldwide and is an
important cause of vision loss and blindness. In vivo animal
models, in vitro cell culture and ex vivo models have been
used for investigating different aspects of this disease, includ-
ing pathogenicity and treatment strategies [1–7].
In vivo studies require the use of a large number of animals
to answer a research question. The welfare of these animals
has become an important ethical issue [8], leading to the pro-
motion of the philosophy of ‘replacement, reduction and re-
finement’ in the use of animals in research [9].
One way to overcome these issues is to use in vitro mono-
layer cultures of cells, including immortalised [5] or primary
[4] corneal epithelial cells. However, these are not representa-
tive of the in vivo situation. They lack a three-dimensional
(3D) structure and cross-talk between different epithelial cells,
limbal cells and keratocytes. Consequently, advances have
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been made in 3Dmulti-layered tissue-engineered corneal con-
structs, and a few of these (EpiOcular™ from Mattek
Corporation, Ashland, MA, USA, and HCE/corneal epitheli-
um (SkinEthic) from Episkin, Lyon, France) are commercially
available [10]. These have been used to study corneal patho-
genesis [6, 11]. Whilst they possess the 3D architecture of
their in vivo counterparts, these models often use
immortalised cell lines and lack intrinsic innate immune mol-
ecules which occur in vivo.
Recently, there has been some interest in the use of ex vivo
corneal models to study keratitis [12, 13]. Although these
models lack immune elements, the 3D architecture remains,
as do the intracellular innate immune molecules and cellular–
stromal components. These models have been used for study-
ing wound healing [14], microbial adherence [12] and molec-
ular microbial pathogenicity [13]. In our laboratory, we have
used ex-vivo corneal models to study corneal epithelial regen-
eration [15, 16] and to develop models of inflammation. We
have also shown that by gently rocking media over the cor-
neas, they can be maintained in culture for at least 4 weeks
[17].
To the best of our knowledge, a comparison of bacterial
and fungal infections and of mixed infections has not been
undertaken in ex vivo corneal models.We report a comparison
of single- and mixed-species infections in both rabbit and
human corneas to better understand the use of these models
in microbial keratitis.
Materials and methods
Materials
We used corneas from two types of rabbits—wild brown rab-
bits (BlackfaceMeat Company, Dumfries, Scotland) and New
Zealand rabbits (University of Sheffield, from rabbits
sacrificed at the end of a licenced study). There was no differ-
ence in the performance of corneas from these two types of
rabbits. Cadaveric human corneas unsuitable for transplant
were acquired from the Ramayamma International Eye
Bank, LV Prasad Eye Institute, Hyderabad, India. All corneas
were obtained following procedures approved by the institu-
tional review board for the protection of human subjects.
Dispase II was obtained from Roche Diagnostics (Burgess
Hill, UK), and Videne® antiseptic solution was purchased
from Ecolab (St. Paul, MN, USA). Mouse 3T3 fibroblasts
(used in India) were from the American Type Culture
Collection (ATCC; Manassas, VA, USA), and those used in
the UK were an established J2 3T3 cell line originally from
Professor Howard Green, USA. Epidermal growth factor was
obtained from Invitrogen (Paisley, UK). For the culture of
microorganisms, brain-heart infusion (BHI) agar and broth
were purchased from Oxoid (Hampshire, UK) or HiMedia
(Mumbai, India). All other reagents were obtained from
Sigma-Aldrich (Dorset, UK) unless otherwise stated.
Calcofluor-white was obtained from Sigma-Aldrich (Dorset,
UK) and from HiMedia (Mumbai, India).
Isolation of rabbit corneas
Corneas with sclera rims were dissected using a standard pro-
cedure including decontamination with povidone iodine, and
were immediately placed into phosphate-buffered saline
(PBS) [15].
Ex vivo corneal organ culture
Organ cultures were as previously described [15, 18]. Rabbit
and human corneoscleral buttons were placed epithelial side
down in 35-mm petri dishes, and 500 μl Dulbecco’s modified
eagle’s medium (DMEM)–agarose (0.5 % w/v) solution was
pipetted into the endothelial side of the cornea. The solution
was allowed to solidify, and the buttons were then inverted so
that the epithelium was facing up (Fig. 1a and b). Culture
medium (DMEM: Ham’s F12 [1:1] supplemented with 10 %
fetal calf serum [FCS], 100 U ml−1 penicillin and 100 U ml−1
streptomycin, 2.5 μg ml−1 amphotericin B, 5 μg ml−1 insulin
and 10 ng ml−1 epidermal growth factor [EGF]) was added to
submerge the ex vivo corneas. Prior to infection, corneas were
washed three times with PBS and incubated in antibiotic- and
antifungal-free medium for at least 24 h to remove residual
antimicrobials.
All experimental work was performed on rabbit corneas in
the UK and on human corneas in India.
Culture of bacteria and fungi
For rabbit corneas, laboratory strains of S. aureus (S-235),
P. aeruginosa (SOM-1), C. albicans (SC5314) and F. solani
strain (NCPF 2699), purchased from the National Collection
of Pathogenic Fungi (UK), were used. For human corneas,
ATCC cultures of S. aureus (25923), P. aeruginosa (27853)
and C. albicans (90028) were used. All bacterial and fungal
strains were cultured on brain-heart infusion (BHI) agar at
37 °C overnight and then maintained at 4 °C. For use in ex-
periments, one colony was sub-cultured from agar into BHI
broth and incubated overnight at 37 °C. Stationary-phase mi-
crobes were used in rabbit cornea experiments. For human
corneal experiments, on the day of corneal inoculation, a fresh
broth was inoculated, and exponential-phase bacteria/fungi
were used based on predetermined growth curves.
Infection of ex vivo corneas
Corneas were wounded with a scalpel (3 slashes vertically and
3 slashes horizontally), and a metal ring was placed on the
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corneoscleral button, creating a watertight seal. Into the centre
of the ring, 108 S. aureus, P. aeruginosa, C. albicans or
F. solani were added (Fig. 1c), or the corneas were injected
intrastromally (using a 26-gauge needle; Becton Dickinson,
Oxford, UK) with the same number of organisms.
The infected corneas were incubated for 24 or 48 h at
37 °C, and were then homogenised and the resulting suspen-
sion serially diluted and spotted onto agar plates for colony
enumeration. A set of infected corneas was also processed for
histology and sections stained using Gram (bacteria) and pe-
riodic acid–Schiff (PAS) stains (fungi). Corneas not exposed
to microbes were used as controls. Histological sections were
imaged using a BX51 upright microscope and cell3D imaging
software (Olympus, Essex, UK) in the UK or the ProgRes
CapturePro 2.5 software (Jenoptik) in India.
Imaging of microorganisms on the corneal surface
To visualise bacteria, 108 S. aureus or P. aeruginosa were
labelled using 1 mg ml−1 fluorescein isothiocyanate (FITC)
for 1 h at 4 °C, followed by four washes with PBS. For fungi,
whole corneas were covered with 1:1 calcofluor white in 10%
(v/v) potassium hydroxide for 10 min and washed three times
with PBS. Bacteria- and fungi-infected corneas were imaged
using fluorescence microscopy as described above.
Statistical analysis
Box-and-whisker plots of colony-forming units (CFU) per
cornea were plotted using GraphPad Prism 6 software. All
comparisons were analysed using Student’s unpaired two-
tailed t test, using Microsoft® Excel (Microsoft® Office,
2010). A p value ≤ 0.05 was considered significant.
Results
Macroscopic view of rabbit and human corneas
Corneas infected with bacteria and fungi showed a visible
increase in haze compared with uninfected corneas (Fig. 2).
The scratches were visible in all corneas, but were more evi-
dent in infected corneas than uninfected corneas (Fig. 2).
FITC-labelled bacteria within infected rabbit and human
corneas are shown in Fig. 3. It was observed that S. aureus
cells covered the surface of the cornea at 24 h and 48 h, and at
certain locations, clumps of bacteria ranging from 5 to 25 μm
in diameter were detected. On the other hand P. aeruginosa-
infected corneas showed fewer clumps than observed with
S. aureus, after 24 and 48 h. Amicroscopic view of the surface
of calcofluor white-stained C. albicans-infected corneas
showed a more uniform spread of yeast and a few hyphal
forms on the surface of the cornea after 24 h, which increased
in both the distribution of individual yeast cells and the spread
of hyphae by 48 h (Fig. 3). The distribution of F. solani at 24 h
was more punctuated with hyphae at distinct places in both
rabbit and human corneas (Fig. 3). After 48 h, the surface of
the cornea was covered with a mat of fungi, where the hyphae
could be observed extending into the scratch and in all direc-
tions, away from the fungal bulk (Fig. 3). The coverage of
bacteria and fungi over the corneal surface was similar be-
tween rabbit and human corneas.
Single-species infection of rabbit and human corneas
After 24 h, CFU recovered per cornea for S. aureus,
P. aeruginosa, C. albicans and F. solani were as follows
(Fig. 4): 5.1 ± 1.0 × 105, 1.9 ± 0.3 × 107, 3.0 ± 0.6 × 105 and
2.5 ± 0.9 × 105 CFU/rabbit cornea, respectively, and 3.8 ±
Culture 
medium
Petri-
dish
Cornea
Sclera
Agarose-culture medium
a b
Sclera
Cornea
Petri-dish
Culture 
medium
c
Fig. 1 Schematic representation
of a cross section (a) and a top-
down image (b) of a corneoscleral
button in organ culture. To infect
corneas, a metal ring was placed
on the corneoscleral button after
wounding to form a seal, and
bacteria/fungi were added to the
surface of the cornea (c)
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0.8 × 106, 4.4 ± 0.6 × 108, 1.9 ± 0.3 × 105 and 1.8 ± 0.1 × 103
CFU/human cornea, respectively. A significantly higher num-
ber of S. aureus and P. aeruginosa were recovered after 48 h
of incubation in both rabbit (1.7 ± 0.3 × 106 (p = 0.00005), 4.4
± 0.7 × 107 (p = 0.0009) and human corneas (1.5 ± 0.4 × 107
(p = 0.0004), 6.5 ± 3.0 × 108 (p = 0.0057), respectively, com-
pared to yields at 24 h. There was no significant difference in
the recovery of C. albicans or F. solani after 48 h, with 5.1 ±
1.5 × 105 (p = 0.159) and 1.6 ± 0.7 × 106 (p = 0.090) CFU/
rabbit cornea, respectively, and 5.3 ± 1.6 × 105(p = 0.108)
and 2.1 ± 0.1 × 103(p = 0.081) CFU/human cornea, respec-
tively. In addition, there was approximately tenfold greater
recovery of bacteria from human corneas than from rabbit
corneas after both 24 and 48 h.
The injection method involved the introduction of bacteria
and fungi into the stroma. Compared to the scalpel method,
after 24 h, injection of a single-species organism resulted in
higher CFU/cornea (p < 0.05) for all organisms, with the ex-
ception of C. albicans in human corneas, where no significant
difference was observed (p = 0.057).
20µm
24h
48h
C.albicans F.solaniS.aureus P.aeruginosa
b
24h
48h
a
Scratch
Scratch
50µm 50µm 50µm
50µm 50µm 50µm 20µm
Fig. 3 FITC-labelled S. aureus or
P. aeruginosa were incubated
with scalpel wounded rabbit (a)
and human (b) corneas for 24 and
48 h, washed and imaged using a
fluorescent microscope.
Unlabelled C. albicans and
F. solani were incubated with
rabbit and human corneas for 24
and 48 h, washed, the model
stained with Calcofluor White
and imaged using a fluorescent
microscope. The distribution of
bacteria and fungi over the
surface of the cornea and located
within the scratch wound can be
observed
snacibla.Csuerua.S P.aeruginosa F.solani Control
RABBIT
HUMAN
Fig. 2 Fluorescein-stained rabbit
and human corneas showing
turbidity of infected versus non-
infected corneas. Corneas were
scalpel-wounded and exposed to
S. aureus, P. aeruginosa,
C. albicans or F. solani for 24 h.
Corneas were briefly washed and
stained with 0.5 mg ml−1 of
fluorescein isothiocyanate for
30 min, washed again and
photographed. Arrows indicate
scalpel wounds
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The histology of single-species-infected corneas after 24 h
is shown in Fig. 5a. Here, vast infiltration of P. aeruginosa can
be seen covering the epithelium and entire stroma and infil-
trating the Descemet’s membrane. This was independent of
the method of inoculation (data not shown). The histology
of the S. aureus-infected corneas was characterised by the
concentration of the majority of organisms within the
scratches (Fig. 5a). The number of bacteria within tissue sec-
tions correlated with the CFU/cornea data (Fig. 4).
The distribution of C. albicans within the corneal tissue
was similar between the human and rabbit corneas. Yeast cells
and hyphal elements were observed close to the scratch site,
with no infiltration beyond 150 μm into the stroma (Fig. 5a).
The number of hyphae and the infiltration of C. albicans cells
into the stroma after 48 h did not differ from that observed
after 24 h.
The tissue penetration by F. solani after scalpel wounding
was less than that for C. albicans at 24 h, with infiltration not
more than 10 μm into the stroma from the site of inoculation
(Fig. 5a), which increased after 48 h in both number and depth
of penetration.
Two-species infection of corneas
In the two-species infection model, we were able to recover
both bacterial species from infected rabbit and human corneas
(Table 1). Histological examination confirmed the quantitative
colony count data (Fig. 6). As with the single-species model,
infiltration of P. aeruginosa cells was found throughout the
stroma, including Descemet’s membrane, whereas S. aureus
showed little spread beyond the injection site.
A mixed infection involving C. albicans and P. aeruginosa
is the most commonly observed clinically [19]. In ex vivo
models of this mixed infection, both organisms were recov-
ered after 24 h following scalpel wounding, with
P. aeruginosa showing dominance within the tissue by both
colony counting (4.20 ± 1.6 × 106 and 2.12 ± 0.9 × 108 CFU/
rabbit cornea and 5.15 ± 6.6 × 105 and 1.00 ± 1.2 × 108 CFU/
human cornea forC. albicans and P. aeruginosa, respectively)
and histology (Table 1 and Fig. 6). The level of recovery of
both organisms was approximately the same regardless of the
method of introduction of organisms.
Discussion
Ex vivo models have previously been used to study corneal–
microbial interactions [12, 13]. However, there have been no
direct comparisons of single and mixed bacterial and fungal
infections or a comparison of the infection of rabbit and hu-
man corneas. Here, we describe the numbers of viable organ-
isms recovered from rabbit and human corneas after 24 and
48 h, showing histological images from scalpel wounding and
intrastromal injection as ways of introducing organisms to the
cornea.
A variety of methods have been described in the literature
for introducing bacteria or fungi to experimental (in vivo,
in vitro or ex vivo) corneas. These include the use of
bacterial/fungal-inoculated contact lenses [20, 21], blotting
paper and ethylene glycol tetraacetic acid (EGTA) [7], and
mechanical removal of the epithelial surface [22, 23].
However, the most commonly described methods are corneal
scratch [24, 25] and intrastromal injection [26, 27]. Therefore,
we chose to scratch the corneas with a scalpel six times, so that
the scratch revealed the upper stromal compartment, and also
to introduce organisms intrastromally using an injection meth-
od. Although the injection method gave a greater yield of
organisms than the scalpel method, we observed that the scal-
pel method mimicked clinical infection in which infection is
initiated from an abrasion on the corneal surface [28]. Because
it was thought that the infiltrative capacity of P. aeruginosa
within the tissue might inhibit or prevent the growth and
Fig. 4 Single-species infection of ex vivo rabbit (a) and human (b)
corneas. Ex vivo corneas were scratched six times with a scalpel and
exposed to single-species inoculum of S. aureus, P. aeruginosa,
C. albicans or F. solani for 24 h at 37 °C. The models were then
homogenised, and the resulting suspension serially diluted and plated
onto agar plates. The number of colony-forming units per cornea were
plotted for each cornea. The box plot shows the minimum and maximum
values depicted by the bars; the upper quartile, median and lower quartile
are depicted by the top, middle and bottom horizontal lines, respectively
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HUMAN
RABBIT
a
b
S.aureus P.aeruginosa C.albicans F.solani
S.aureus P.aeruginosa C.albicans F.solani
HUMAN
RABBIT
Fig. 5 Histology of single-species infection of ex vivo rabbit and human
corneas. Ex vivo rabbit and human corneas were scratched six times with
a scalpel and exposed to a single-species inoculum of S. aureus,
P. aeruginosa, C. albicans or F. solani for 24 h (a) or 48 h (b). Corneas
were fixed in 10 % buffered formalin, embedded in paraffin, sectioned
and stained using Gram stain (S. aureus and P. aeruginosa) or PAS stain
(C. albicans and F. solani). Gram-positive (purple) cocci (S. aureus),
Gram-negative (pink) rods (P. aeruginosa), and purple round yeast and
hyphae (C. albicans and F. solani) can be observed at the epithelial
surface and within the scratch, and are present in the stroma
Table 1 Numbers of CFU/cornea recovered from multi-bacterial/fungal infections after 24 h
A
RABBIT HUMAN
S. aureus - P. aeruginosa S. aureus P. aeruginosa S. aureus P. aeruginosa
1.88 ± 0.6 × 106 3.09 ± 0.9 × 107 5.25 ± 1.6 × 105 2.43 ± 3.2 × 108
C. albicans - P. aeruginosa C. albicans P. aeruginosa C. albicans P. aeruginosa
4.20 ± 1.6 × 106 2.12 ± 0.9 × 108 5.15 ± 6.6 × 105 1.00 ± 1.2 × 108
B
RABBIT HUMAN
S. aureus - P. aeruginosa S. aureus P. aeruginosa S. aureus P. aeruginosa
9.26 ± 4.2 × 106 5.83 ± 2.4 × 108 2.50 ± 5.7 × 104 3.72 ± 1.08 × 108
C. albicans - P. aeruginosa C. albicans P. aeruginosa C. albicans P. aeruginosa
4.25 ± 1.1 × 106 6.84 ± 0.6 × 108 4.05 ± 9.6 × 105 7.65 ± 1.0 × 108
Two multi-pathogen infections were investigated. These were a mixed S. aureus/P. aeruginosa and a mixed C. albicans/P. aeruginosa infection. A: EX
vivo rabbit and human corneas were wounded with a scalpel and exposed to a mixture of 108 of both organisms for 24 h B: Ex vivo rabbit and human
corneas were intrastromally injected with 108 cells of the first organism at 3–5 distinct locations, and then 108 cells of the second organism were
similarly injected at different sites. The corneas were incubated for 24 h, washed, homogenised, serially diluted and plated onto agar plates, and the CFU/
cornea calculated. Data is expressed in CFU/cornea ± SEM of at least three independent experiments performed in triplicate
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propagation of S. aureus and/or C. albicans when introduced
together through a scalpel wound, we compared this method
with intrastromal injection, injecting organisms at separate
sites and thus preventing their interaction. However, the scal-
pel method did not prevent the recovery of S. aureus or
C. albicans, suggesting that either method is suitable for es-
tablishing a mixed infection model. Therefore, we show that
an infection can be induced in the ex vivo corneas for both
single and multiple species using either scalpel wounding or
intrastromal injection.
The following aspects of this model need further
discussion:
1. A large bacterial/fungal inoculum was used, because this
corneal model does not have a blood supply or immune
system. Consequently, the damage that the inflammation
causes to the local tissue, and which provides additional
nutrients via the vasculature for the bacteria/fungi, was
not present.
2. S. aureus was not typically found at the epithelial surface,
but rather within the scratches, commonly in clusters, and
not migrating into surrounding and deeper cornea. This
has been described previously as well [29, 30]. The ob-
served attachment of S. aureus at the stromal surface is
also supported by the observations of Rhem et al. [29],
who demonstrated that collagen-binding clinical S. aureus
isolates expressing the cna collagen-binding gene showed
enhanced tissue disruption compared to a cna− isogenic
mutant. The cna protein is considered to be a virulence
factor mediating bacterial adherence to the epithelial sur-
face and the stroma, and neutrophil recruitment to the
infection site. Of the two strains of S. aureus that we used
in this study, the ATCC 25923 strain is known to express
this gene [31], which could be the reason for the higher
level of binding within the scratch than at the surface (it is
unknown whether this gene is expressed in the local clin-
ical strain, S235). According to reports in the literature,
in vivo corneas infected with S. aureus by intrastromal
injection returned bacterial counts of approximately
104–107 CFU/cornea [32, 33], depending on the number
of bacteria in the starting inoculum and the length of time
the bacteria were incubated with the eye. These values are
in line with the recovery we obtained from ex vivo
models, suggesting that our model is representative of
an in vivo infection in terms of the number of bacteria
recovered.
3. We did not observe any ulceration or corneal edema. This
is because ex vivo corneas lack inflammatory cells that are
primarily responsible for epithelial ulceration [32], stro-
mal polymorphonuclear neutrophil (PMN) infiltration
[34–36], and ulcer formation [37] seen in clinical
S. aureus infection.
4. Compared to the S. aureus model, P. aeruginosa-infected
corneas yielded a greater number of CFU/cornea and were
HUMAN
RABBIT
Scalpel Injection
P.aeruginosa
S.aureus
P.aeruginosa
S.aureus
P.aeruginosa
S.aureusP.aeruginosa
S.aureus
Fig. 6 Histology of rabbit and human ex vivo models showing a mixed
S. aureus and P. aeruginosa infection. At different sites within the same
cornea, ex vivo corneas were intrastromally injected with 108 S. aureus
and 108 P. aeruginosa and incubated for 24 h (injection). Alternatively,
corneas were wounded with a scalpel, and 108 S. aureus and 108
P. aeruginosa were added to the surface of the cornea for 24 h (scalpel).
Sections were Gram-stained and imaged to visualise S. aureus and
P. aeruginosa within their injection sites at distinct locations within the
stroma. P. aeruginosa shows widespread infiltration into the tissue,
whereas S. aureus shows less infiltration
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seen infiltrating the entire cornea, despite having the same
inoculum. This high level of infiltration has been shown
to be the result of proteolytic bacterial enzymes, including
type III secretion system-associated cytotoxins, exoen-
zyme U and exoenzyme S [38, 39], alkaline protease
and elastase [40], which have been shown to contribute
to corneal erosion [41]. In addition, host proteolytic en-
zymes also contribute to corneal ulceration [26]. We ob-
served a softening of P. aeruginosa-infected corneas and
increased opacity compared with control corneas, but no
ulceration. As mentioned previously, this was due to the
lack of an immune cell component in these ex vivo
cultures.
5. Previous studies have reported an increase in the recovery
of P. aeruginosa from corneas compared with the initial
inoculum [42, 43]. However, we did not find this in-
creased recovery of P. aeruginosa. Although we have no
definitive explanation for this observation, one possible
explanation is that only a portion of these organisms ac-
tually adhere to the corneal surface and are able to invade/
colonise. The data presented suggest that 106–107 CFU/
cornea is the maximum number that can be recovered
from an ex vivo cornea, and this maximal amount occurs
after 24 h.
6. In contrast to the bacterial infections, single-species infec-
tions with C. albicans and F. solani did not show a sig-
nificant increase in the recovery of organisms after 48 h
versus 24 h, and the numbers of organisms recovered
were lower, despite the same inoculum. This has been
described briefly in the literature, where as many as
109–106 CFU/cornea for C. albicans and 103 CFU/
cornea for F. solani were inoculated into in vivo or
ex vivo murine, rabbit or rat models, with recovery of as
little as 105–103C. albicansCFU/cornea [12, 44–46], and
103 F. solani CFU/cornea [47], respectively. The reason
for this is not fully understood.
7. From the 24-h histology images presented here, little in-
filtration of fungi into the corneal tissue is seen, with or-
ganisms remaining predominantly at the surface.
However, particularly for F. solani, there was vast infiltra-
tion of fungal cells throughout the stroma after 48 h. The
histology of infected in vivo cultures mimics histological
images of clinical infection, with a dense white fungal
plaque, corneal opacity, corneal infiltration, oedema, ulcer
formation, satellite lesions, corneal neovascularisation
and hypopyon [47–51]. Yeast forms of C. albicans and
conidia of F. solani are shown to adhere to the stroma, and
after a period of time, hyphae form that penetrate the
stroma [12, 45, 52] to a depth of approximately 150 μm
[44]. This was observed in our ex vivo rabbit and human
cornea models.
8. Differences were observed between rabbit and human
corneas primarily in the number of organisms recovered
from each cornea, i.e. there was an approximately tenfold
increase in the recovery of bacteria from human versus
rabbit corneas. This may have been due to the use of
different bacterial strains (ATTC strains [human] and lo-
cal clinical strains [rabbit]), intrinsic differences between
the corneas of the two species, including anatomical and
molecular differences such as differences in the
Bowman’s membrane [44] arrangement of collagen fibres
[53], size, thickness [54], secretion of antimicrobial pep-
tides [55], or surface mucin modifications [56].
Furthermore, the difference in bacterial recovery could
be due to the use of stationary-phase organisms in rabbit
experiments and log-phase bacteria in human corneal ex-
periments. However, in comparing these two types of in-
ocula, we have established that a similar number of bac-
teria in either phase still results in a clinically relevant
level of infection for both single- and multi-species infec-
tion in both corneas, showing comparable histology.
9. The length of time these models were cultured in vitro
was short. The acute nature of such an infection limits
its use to short-term experiments involving, for example,
investigation of treatment strategies [57], innate immune
responses [58], detection of organisms [59] and host–mi-
crobe interactions [18]. These models were not intended
to replicate the clinical outcome of infection that can be
observed in vivo, which may develop over several weeks
when not treated effectively. In these ex vivo models,
there is an obvious lack of a host immune component,
and the presence and infiltration of inflammatory cells is
thought to contribute to the severity of disease [26]. As
such, these ex vivo models do not form corneal ulcers as
typically observed clinically [18, 41, 48]. They also lack
tear films, which play a defensive role.
In summary, we achieved our aim of establishing a repro-
ducible infection of both human and animal corneas. It is
certain that no model system (including animals) is a perfect
surrogate for the natural human infection. Nonetheless, useful
data can still be obtained. We show that we can establish a
reproducible in vitro bacterial and fungal infection, with the
final number of recoverable bacteria/fungi comparable to that
from natural in vivo experiments. These models are now being
used in the evaluation of microbial detection systems.
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